Posted 5th March 2018
The Trust has today accepted the resignation of Chief Executive Andrew Cannell.
Following the discovery of an undisclosed close personal relationship with another member of the senior executive team, Mr Cannell has come to the decision that it would no longer be in the best interest of the Trust for him to continue in his role at The Clatterbridge Cancer Centre.
The Trust would like to thank him for the significant work he has undertaken during his time at The Clatterbridge Cancer Centre. He has overseen an important period of change for the organisation as part of plans to transform cancer care in the region. His vision and commitment has ensured we are able to provide the very best care for our patients both now and into the future.
We will now begin an independent investigation into the matter. The Trust has taken the decision to suspend Mr Cannell and Deputy Chief Executive Yvonne Bottomley whilst that investigation takes place; this in line with both NHS and organisational policy.
The instigation of that investigation does not relate to issues of patient care, safety or financial impropriety.
Barney Schofield, Director of Operations and Transformation, will be taking on the role of Acting Chief Executive and overseeing an experienced and focused executive team to ensure there is no effect on the continued delivery of the outstanding cancer care our Trust is recognised for.